Thus, here we hypothesise that TRD patients have the strongest mRNA-based evidence of inflammation and glucocorticoid resistance, as shown by higher expression of IL-1-beta, IL-6, TNF-alpha and MIF, together with lower GR, higher FKBP5 and higher SGK1 expression. This evidence concerns the gene TNF and treatment resistant depression.